retatrutide nonalcoholic fatty liver disease trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a retatrutide nonalcoholic steatohepatitis nash trial
Pay in 4 interest-free payments of $5.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4























